146 related articles for article (PubMed ID: 21904911)
1. A novel canine model of portal vein stenosis plus thioacetamide administration-induced cirrhotic portal hypertension with hypersplenism.
Lin D; Wu X; Ji X; Zhang Q; Lin Y; Chen W; Jin W; Deng L; Chen Y; Chen B; Li J
Cell Biochem Biophys; 2012 Jan; 62(1):245-55. PubMed ID: 21904911
[TBL] [Abstract][Full Text] [Related]
2. A modified canine model of portal hypertension with hypersplenism.
Chen Y; Zhang Q; Liao Y; Guo F; Zhang Y; Zeng Q; Jin W; Shi H; Zhou M
Scand J Gastroenterol; 2009; 44(4):478-85. PubMed ID: 19096979
[TBL] [Abstract][Full Text] [Related]
3. A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited.
Laleman W; Vander Elst I; Zeegers M; Servaes R; Libbrecht L; Roskams T; Fevery J; Nevens F
Eur J Clin Invest; 2006 Apr; 36(4):242-9. PubMed ID: 16620286
[TBL] [Abstract][Full Text] [Related]
4. Partial portal vein ligation plus thioacetamide: a method to obtain a new model of cirrhosis and chronic portal hypertension in the rat.
Méndez-López M; Méndez M; Sánchez-Patán F; Casado I; Aller MA; López L; Corcuera MT; Alonso MJ; Nava MP; Arias J; Arias JL
J Gastrointest Surg; 2007 Feb; 11(2):187-94. PubMed ID: 17390171
[TBL] [Abstract][Full Text] [Related]
5. Partial splenectomy, transposition of the spleen to the abdominal wall or splenohepatoplasty in portal hypertensive rats. Effects on portal venous pressure and homeostasis--microscopical appearance of the transposed spleen.
Tröbs RB; Bennek J
Eur J Pediatr Surg; 1998 Jun; 8(3):155-62. PubMed ID: 9676398
[TBL] [Abstract][Full Text] [Related]
6. A canine portal hypertension model induced by intra-portal administration of Sephadex microsphere.
Jin W; Deng L; Zhang Q; Lin D; Zhu J; Chen Y; Chen B; Li J
J Gastroenterol Hepatol; 2010 Apr; 25(4):778-85. PubMed ID: 20492334
[TBL] [Abstract][Full Text] [Related]
7. Correlations of portal hypertensive gastropathy of hepatitis B cirrhosis with other factors.
Pan WD; Xun RY; Chen YM
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):527-31. PubMed ID: 14607680
[TBL] [Abstract][Full Text] [Related]
8. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution.
Hsu SJ; Tsai MH; Chang CC; Hsieh YH; Huang HC; Lee FY; Chuang CL; Hou MC; Lee SD
Clin Sci (Lond); 2018 Mar; 132(6):669-683. PubMed ID: 29449343
[TBL] [Abstract][Full Text] [Related]
9. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions.
Bolognesi M; Sacerdoti D; Merkel C; Gerunda G; Maffei-Faccioli A; Angeli P; Jemmolo RM; Bombonato G; Gatta A
Hepatology; 1996 May; 23(5):1035-40. PubMed ID: 8621130
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of children with extrahepatic portal vein obstruction: impact of an endoscopic sclerotherapy program on bleeding episodes, hepatic function, hypersplenism, and mortality.
Maksoud-Filho JG; Gonçalves ME; Cardoso SR; Gibelli NE; Tannuri U
J Pediatr Surg; 2009 Oct; 44(10):1877-83. PubMed ID: 19853741
[TBL] [Abstract][Full Text] [Related]
11. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic portal hypertension and its pathology.
Okudaira M; Ohbu M; Okuda K
Semin Liver Dis; 2002 Feb; 22(1):59-72. PubMed ID: 11928079
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamics in the microvasculature of thioacetamide-induced cirrhotic rat livers.
Nakata M; Nakamura K; Koda Y; Kaminou T; Ugami M; Kaneda K; Yamada R
Hepatogastroenterology; 2002; 49(45):652-6. PubMed ID: 12063962
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAome of splenic macrophages in hypersplenism due to portal hypertension in hepatitis B virus-related cirrhosis.
Li Z; Zhang S; Huang C; Zhang W; Hu Y; Wei B
Exp Biol Med (Maywood); 2008 Nov; 233(11):1454-61. PubMed ID: 18791127
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and experimental studies on elevated plasma level of insulin in cirrhotic patients with portal hypertension and portosystemic collateral circulation].
Arakawa T
Nihon Geka Gakkai Zasshi; 1984 May; 85(5):468-81. PubMed ID: 6379413
[TBL] [Abstract][Full Text] [Related]
16. [Experimental observation of high portal venous resistance in dogs].
Wang WM
Zhonghua Yi Xue Za Zhi; 1993 Jun; 73(6):349-51, 381. PubMed ID: 8258105
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis.
Gao JH; Wen SL; Yang WJ; Lu YY; Tong H; Huang ZY; Liu ZX; Tang CW
PLoS One; 2013; 8(7):e69309. PubMed ID: 23922700
[TBL] [Abstract][Full Text] [Related]
18. Clinical and laboratory predictors of esophageal varices in children and adolescents with portal hypertension syndrome.
Fagundes ED; Ferreira AR; Roquete ML; Penna FJ; Goulart EM; Figueiredo Filho PP; Bittencourt PF; Carvalho SD; Albuquerque W
J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):178-83. PubMed ID: 18223377
[TBL] [Abstract][Full Text] [Related]
19. [Radiofrequency ablation for hypersplenism due to portal hypertension: clinical study].
Liu QD; Ma KS; He ZP; Wu Q; Zhou NX; Dong JH
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(15):1031-4. PubMed ID: 16029544
[TBL] [Abstract][Full Text] [Related]
20. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism.
Kawanaka H; Akahoshi T; Kinjo N; Konishi K; Yoshida D; Anegawa G; Yamaguchi S; Uehara H; Hashimoto N; Tsutsumi N; Tomikawa M; Maehara Y
Ann Surg; 2010 Jan; 251(1):76-83. PubMed ID: 19864937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
